Shrinyadi Leha and its Syrup in Cough

Study of Shrinyadi Leha and its Syrup in Kaphaja Kasa

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032674

Enrollment

Registered

2021-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J06- Acute upper respiratory infections

Interventions

Intervention1: A clinical study of Shringyadi Leha and its Syrup in Kaphaja Kasa: karkatshringi, musta, ativisha, madhu Intervention2: Shringyadi Leha Shringyadi Syrup : KARKATSHRINGI, MUSTA, ATIVISH

Eligibility

Inclusion criteria

Inclusion criteria: Age >5 year Cough with sputum

Exclusion criteria

Exclusion criteria: Age 16 year Cough associated with known case of other Respiratory disorder like Bronchial Asthma, Tuberculosis, Pulmonary Eosinophilia, Loffler syndrome or any other systemic diseases. Cough associated with severe malnutrition. Cough associated with known case of neurological disorder.

Design outcomes

Primary

Measure	Time frame
reduction in symptoms like shortness in breathe, excessive hunger, excessive sleep, nasal dischargeTimepoint: the patient will be followed up at 5-5 days	—

Secondary

Measure	Time frame
reduction in symptoms like reduction in cough, reduction bouts, reduction in sputumTimepoint: 1st two follow up will be carried out at interval of 5-5 days. Next two follow up will be carried out at the interval of 10- 10 days (if required).	—

Countries

India

Contacts

Public ContactUsha Sharma

Rishikul Haridwar

ushaojha62@gmail.com9219618264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026